Literature DB >> 19536654

Matrix metalloproteinase-9 gene and bipolar mood disorder.

Janusz K Rybakowski1, Maria Skibinska, Anna Leszczynska-Rodziewicz, Leszek Kaczmarek, Joanna Hauser.   

Abstract

Matrix metalloproteinase-9 (MMP-9) plays a role in many pathological conditions (e.g., cancer and heart disease). Recently, MMP-9 has been implicated in various aspects of brain functions (e.g., neuroplasticity and epileptogenesis) and thus, we hypothesized that MMP-9 gene may be associated with bipolar mood disorder. The study was performed on 416 patients with bipolar mood disorder, including 75 patients with bipolar II type of the illness, and in 558 healthy control persons. A functional -1562C/T polymorphism of the MMP-9 gene was genotyped in all subjects. Patients with bipolar mood disorder had significant preponderance of T allele versus C allele of 1562C/T polymorphism of the MMP-9 gene, compared to healthy control subjects. The higher frequency of T allele compared to healthy subjects was especially evident in a subgroup of patients with bipolar disorder, type II. The results may provide the first evidence for an involvement of the MMP-9 gene in the pathogenesis of bipolar mood disorder. They may also contribute to explaining genetic connection between bipolar mood disorder and some somatic illnesses. In the light of our results obtained with this polymorphism in schizophrenia, we speculate that the MMP-9 gene may be a common susceptibility gene to major psychoses with different allelic variants occurring in bipolar illness and schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19536654     DOI: 10.1007/s12017-009-8072-3

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  26 in total

1.  The functional MMP-9 microsatellite marker is not associated with episodic memory in humans.

Authors:  Evangelos Vassos; Xiaohong Ma; Nicola Fiotti; Qiang Wang; Pak C Sham; Xiehe Liu; Yingcheng Wang; Chengying Yan; Huaqing Meng; Wei Deng; David A Collier; Tao Li
Journal:  Psychiatr Genet       Date:  2008-10       Impact factor: 2.458

2.  Common sequence variants on 20q11.22 confer melanoma susceptibility.

Authors:  Kevin M Brown; Stuart Macgregor; Grant W Montgomery; David W Craig; Zhen Zhen Zhao; Kelly Iyadurai; Anjali K Henders; Nils Homer; Megan J Campbell; Mitchell Stark; Shane Thomas; Helen Schmid; Elizabeth A Holland; Elizabeth M Gillanders; David L Duffy; Judith A Maskiell; Jodie Jetann; Megan Ferguson; Dietrich A Stephan; Anne E Cust; David Whiteman; Adele Green; Håkan Olsson; Susana Puig; Paola Ghiorzo; Johan Hansson; Florence Demenais; Alisa M Goldstein; Nelleke A Gruis; David E Elder; Julia Newton Bishop; Richard F Kefford; Graham G Giles; Bruce K Armstrong; Joanne F Aitken; John L Hopper; Nicholas G Martin; Jeffrey M Trent; Graham J Mann; Nicholas K Hayward
Journal:  Nat Genet       Date:  2008-05-18       Impact factor: 38.330

Review 3.  Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections?

Authors:  Leszek Kaczmarek; Joanna Lapinska-Dzwonek; Sylwia Szymczak
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

4.  Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus.

Authors:  Arek Szklarczyk; Joanna Lapinska; Marcin Rylski; Ronald D G McKay; Leszek Kaczmarek
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

5.  Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.

Authors:  B Zhang; S Ye; S M Herrmann; P Eriksson; M de Maat; A Evans; D Arveiler; G Luc; F Cambien; A Hamsten; H Watkins; A M Henney
Journal:  Circulation       Date:  1999-04-13       Impact factor: 29.690

6.  Early onset bipolar disorder: possible linkage to chromosome 9q34.

Authors:  Stephen V Faraone; Jessica Lasky-Su; Stephen J Glatt; Paul Van Eerdewegh; Ming T Tsuang
Journal:  Bipolar Disord       Date:  2006-04       Impact factor: 6.744

7.  Functional polymorphism of the matrix metalloproteinase-9 (MMP-9) gene in schizophrenia.

Authors:  Janusz K Rybakowski; Maria Skibinska; Pawel Kapelski; Leszek Kaczmarek; Joanna Hauser
Journal:  Schizophr Res       Date:  2009-03-04       Impact factor: 4.939

Review 8.  Common risk genes for affective and schizophrenic psychoses.

Authors:  Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

9.  Enhanced cancer risk among patients with bipolar disorder.

Authors:  Micha BarChana; Itzhak Levav; Irena Lipshitz; Inna Pugachova; Robert Kohn; Abraham Weizman; Alexander Grinshpoon
Journal:  J Affect Disord       Date:  2007-09-27       Impact factor: 4.839

10.  Important role of matrix metalloproteinase 9 in epileptogenesis.

Authors:  Grzegorz M Wilczynski; Filip A Konopacki; Ewa Wilczek; Zofia Lasiecka; Adam Gorlewicz; Piotr Michaluk; Marcin Wawrzyniak; Monika Malinowska; Pawel Okulski; Lukasz R Kolodziej; Witold Konopka; Kamila Duniec; Barbara Mioduszewska; Evgeni Nikolaev; Agnieszka Walczak; Dorota Owczarek; Dariusz C Gorecki; Werner Zuschratter; Ole Petter Ottersen; Leszek Kaczmarek
Journal:  J Cell Biol       Date:  2008-03-10       Impact factor: 10.539

View more
  14 in total

Review 1.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

Review 2.  Matrix Metalloproteinase-9 as a Novel Player in Synaptic Plasticity and Schizophrenia.

Authors:  Katarzyna Lepeta; Leszek Kaczmarek
Journal:  Schizophr Bull       Date:  2015-04-02       Impact factor: 9.306

3.  Osteoprotegerin levels in patients with severe mental disorders.

Authors:  Sigrun Hope; Ingrid Melle; Pål Aukrust; Ingrid Agartz; Steinar Lorentzen; Nils Eiel Steen; Srdjan Djurovic; Thor Ueland; Ole A Andreassen
Journal:  J Psychiatry Neurosci       Date:  2010-09       Impact factor: 6.186

Review 4.  Losing the sugar coating: potential impact of perineuronal net abnormalities on interneurons in schizophrenia.

Authors:  Sabina Berretta; Harry Pantazopoulos; Matej Markota; Christopher Brown; Eleni T Batzianouli
Journal:  Schizophr Res       Date:  2015-01-16       Impact factor: 4.939

5.  Neurocan regulates vulnerability to stress and the anti-depressant effect of ketamine in adolescent rats.

Authors:  Zhoulong Yu; Ying Han; Die Hu; Na Chen; Zhongyu Zhang; Wenxi Chen; Yanxue Xue; Shiqiu Meng; Lin Lu; Wen Zhang; Jie Shi
Journal:  Mol Psychiatry       Date:  2022-03-09       Impact factor: 13.437

6.  Genetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients.

Authors:  Antonio Drago; Barbara Monti; Diana De Ronchi; Alessandro Serretti
Journal:  Neuropsychobiology       Date:  2014-02-27       Impact factor: 2.328

Review 7.  Response to lithium in bipolar disorder: clinical and genetic findings.

Authors:  Janusz K Rybakowski
Journal:  ACS Chem Neurosci       Date:  2014-03-25       Impact factor: 4.418

8.  Postnatal LPS Challenge Impacts Escape Learning and Expression of Plasticity Factors Mmp9 and Timp1 in Rats: Effects of Repeated Training.

Authors:  Alexander Trofimov; Tatyana Strekalova; Niall Mortimer; Olga Zubareva; Alexander Schwarz; Evgeniy Svirin; Aleksei Umriukhin; Andrei Svistunov; Klaus-Peter Lesch; Victor Klimenko
Journal:  Neurotox Res       Date:  2017-04-18       Impact factor: 3.911

9.  Matrix Metalloproteinase-9 (MMP9)-A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders.

Authors:  Janusz K Rybakowski
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-08-31

Review 10.  Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.

Authors:  Janusz K Rybakowski
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.